- Home
- CMBM vs BFRI Comparison
CMBM vs BFRI Comparison
Compare CMBM & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMBM
- BFRI
- Stock Information
- Founded
- CMBM 2011
- BFRI 1997
- Country
- CMBM United States
- BFRI United States
- Employees
- CMBM 625
- BFRI N/A
- Industry
- CMBM Radio And Television Broadcasting And Communications Equipment
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- CMBM Technology
- BFRI Health Care
- Exchange
- CMBM Nasdaq
- BFRI Nasdaq
- Market Cap
- CMBM 9.6M
- BFRI 7.5M
- IPO Year
- CMBM 2019
- BFRI 2021
- Fundamental
- Price
- CMBM $0.40
- BFRI $0.62
- Analyst Decision
- CMBM Strong Buy
- BFRI Strong Buy
- Analyst Count
- CMBM 2
- BFRI 1
- Target Price
- CMBM $5.50
- BFRI $2.75
- AVG Volume (30 Days)
- CMBM 5.2M
- BFRI 188.4K
- Earning Date
- CMBM 08-07-2025
- BFRI 08-13-2025
- Dividend Yield
- CMBM N/A
- BFRI N/A
- EPS Growth
- CMBM N/A
- BFRI N/A
- EPS
- CMBM N/A
- BFRI N/A
- Revenue
- CMBM $172,215,000.00
- BFRI $37,997,000.00
- Revenue This Year
- CMBM N/A
- BFRI $11.75
- Revenue Next Year
- CMBM $17.87
- BFRI $17.09
- P/E Ratio
- CMBM N/A
- BFRI N/A
- Revenue Growth
- CMBM N/A
- BFRI 14.28
- 52 Week Low
- CMBM $0.23
- BFRI $0.54
- 52 Week High
- CMBM $2.97
- BFRI $2.22
- Technical
- Relative Strength Index (RSI)
- CMBM 54.18
- BFRI 45.79
- Support Level
- CMBM $0.38
- BFRI $0.61
- Resistance Level
- CMBM $0.41
- BFRI $0.66
- Average True Range (ATR)
- CMBM 0.04
- BFRI 0.05
- MACD
- CMBM 0.01
- BFRI 0.00
- Stochastic Oscillator
- CMBM 90.38
- BFRI 35.00
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.